C12Y 603/00
Ligases forming carbon-nitrogen bonds
Official title: Ligases forming carbon-nitrogen bonds (6.3)
C12Y603/00 (Ligases forming carbon-nitrogen bonds) appears on 316 US grants and 612 published applications in this corpus.
Search patents in C12Y- Granted patents
- 316
- Published applications
- 612
- Assignees
- 324
- Inventors
- 1,315
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 6 |
| 2004 | 1 | 13 |
| 2005 | 2 | 12 |
| 2006 | 3 | 12 |
| 2007 | 7 | 4 |
| 2008 | 5 | 9 |
| 2009 | 5 | 5 |
| 2010 | 3 | 8 |
| 2011 | 4 | 7 |
| 2012 | 5 | 14 |
| 2013 | 6 | 20 |
| 2014 | 6 | 52 |
| 2015 | 23 | 36 |
| 2016 | 25 | 37 |
| 2017 | 23 | 36 |
| 2018 | 16 | 39 |
| 2019 | 17 | 34 |
| 2020 | 24 | 33 |
| 2021 | 18 | 30 |
| 2022 | 30 | 50 |
| 2023 | 17 | 34 |
| 2024 | 15 | 34 |
| 2025 | 27 | 49 |
| 2026 | 24 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Modified UBE3A gene for a gene therapy approach for Angelman syndrome15 Sep 2026US 12,734,250 B2University of South Florida
- Mutant enzyme, use thereof and process for preparing tripeptide by using enzymatic method15 Sep 2026US 12,735,694 B2Shenzhen Readline Biotech Co., Ltd.
- Glutamine-hydrolyzing GMP synthase variant and method for producing purine nucleotide by using same1 Sep 2026US 12,723,242 B2Cj Cheiljedang Corporation
- Antibodies against human and canine IL-13RA225 Aug 2026US 12,715,926 B2Wake Forest University Health Sciences
- Hyaluronic acid-producing recombinant cells14 Jul 2026US 12,680,121 B2Givaudan SA
- Bacterial glutamine synthetase as selection marker in mammalian cells24 Sep 2026US 2026/0286381 A1Boehringer Ingelheim International GmbH
- Biocatalytic synthesis of unnatural mycosporine-like amino acids17 Sep 2026US 2026/0272801 A1University of Florida Research Foundation, Inc.
- Generation of landing pad cell lines10 Sep 2026US 2026/0265781 A1Bristol-Myers Squibb Company
- Methods for carbon-conserving cell-free bioproduction27 Aug 2026US 2026/0250724 A1Battelle Memorial Institute
- Bioelectric hybrid system producing lactic acid from carbon dioxide20 Aug 2026US 2026/0242832 A1Korea Advanced Institute of Science and Technology
Most cited
By later US patents
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding basic helix-loop-helix family member E41125US 9,107,886 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1124US 9,095,552 B2Moderna Therapeutics, Inc. · 2015